Lyndra Therapeutics raises $55 million from Gilead and Gates - STAT

Lyndra Therapeutics raises $55 million from Gilead and Gates - STAT

More reads

• It’s not just Democrats: In dueling drug pricing hearings, at least some Republicans slam pharma, too. (STAT)
• FDA back in business after shutdown, but regulatory work has 'piled up.' (S&P Global)
• Following the M&A money, by phase and therapy area. (EP Vantage)
• Lyndra Therapeutics raises $55 million from Gilead and Gates. (STAT Plus)